Skip to main content
DNLI logo

DNLI · Denali Therapeutics Inc. · Share Buybacks

Track DNLI — free
$19.28 -0.63 (-3.16%)
Market Cap
$3.25B
Shares
159.85M
Volume · Oct 6 3.67M Avg daily vol (3M) 1.57M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2025-02 $400,000,000 — —
Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 7 filings 7 filers Visit website Investor relations